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ABSTRACT 
The mechanisms regulating the differentiation of naive 
CD4 T cells into Th1/Th2 subsets have been intensively 
investigated in the mouse. This report summarizes the 
current knowledge regarding naive human CD4 T cell 
maturation in vitro. The Th1/Th2 dichotomy is less 
absolute in human than in mouse T cells; indeed, 
unlike their murine counterparts, human Th2 cells 
retain the capacity for responding to and of inducing 
the production of interleukin (IL)-12. When adequately 
stimulated, naive CD4 T cells release not only IL-2, but
olso high levels of type 1 cytokines (interferon (IFN)-γ,
lymphotoxin and tumor necrosis factor (TNF)-α) as well
as low levels of type 2 cytokines (IL-4, IL-13 and IL-10). 
Interleukin-4 may be produced by every single naive 
T cell at very low levels that are sufficient to promote 
the acquisition of a Th2 phenotype upon repetitive 
stimulation in the absence of exogenous cytokine. 
Interleukin-12 primes naive T cells for increased pro-
duction of IFN-γ, decreased production of IL-4 and
IL-5 and increased responsiveness to IL-12. The effects
of IL-12 on IFN-γ and IL-5 as well as on IL-12 respon-
siveness are prolonged, whereas those on IL-4 are 
transient. However, repetitive stimulation in the pres-
ence of IL-12 leads to Thl effectors. Thus, IL-12 is 
required not only for the induction but also for the 
development and maintenance of a Th1 response. 
Upon interaction with dendritic cells (DC), naive T cells
produce several cytokines (IL-4, IFN-γ) and express
CD40L, which triggers IL-12 production by DC. The 
balance between these endogenously produced 
cytokines determines the lymphokine-producing 
phenotype of primed cells, this balance depending 
upon the genetic background, the nature and the 
strength of the T-cell-receptor-mediated signal and the 
activation state of DC. 
Key words: naive CD4 T cells, Th1 effectors, Th2 
effectors.
INTRODUCTION
The great majority of mouse CD4+ T cell clones may be 
classified into three major subsets defined by their 
cytokine production profile.' Thl cells produce high lev-
els of interleukin (IL)-2, interferon (IFN)-γ and tumor
necrosis factor (TNF)-β but no IL-4 or IL-5; Th2 cells pro-
duce high levels of IL-4, IL-5, IL-6, IL-10 and IL-13 but no
IL-2 or IFN-γ; and Th0 cells produce both type 1 and type
2 cytokines. Although the same classification applies 
to human T cell clones, there are significant differences 
between human and mouse Th subsets.2 First, in the 
human system, IL-10 and IL-13 may be produced by both 
Thl and Th2 cells. Second and more important, human 
Th2 cell clones retain the ability to produce hiah levels of
IL-2 and IFN-γ when adequately stimulated, including,
for example, with phorbol esters plus ionomycin.3 More-
over, unlike their murine counterparts, human Th2 cells 
still respond to IL-12 and are capable of inducing IL-12 
production by dendritic cells (DC).4'5 These Th subsets are 
not an in vitro artefact resulting from the T cell cloning 
procedures; indeed, they have been identified in vivo.6 
Moreover, some immune responses are characterized by
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the predominant accumulation of one Th cell subset and 
are, therefore, named type 1 or type 2 responses. The 
polarization of the immune response is not absolute, so 
low and varying numbers of Th0 or even,Th1 cells may be 
present in a polarized Th2 response and vice versa. Th1 
and Th2 cells cross-inhibit each other's functions and cel-
lular expansion, explaining, in part, the development and 
the persistence of polarized type 1 or type 2 responses. 
The major function of Th1 cells is to activate macro-
phages for increased bactericidal activity and enhanced 
production of pro-inflammatory molecules. Th1 cells also 
display Fas-ligand-mediated cytotoxicity7 and are capa-
ble of inducing complement fixing and opsonizing anti-
bodies. Th1 cells play an obligatory role in the protection 
against several pathogens with an obligatory or faculta-
tive intracellular cycle. The major function of Th2 cells is 
to help B cells for IgE as well as IgG and IgA antibody 
production and to promote the differentiation, recruit-
ment and activation of eosinophils, basophils and mast 
cells. Th2 cells are involved in protective immunity 
against some parasites; they also down-regulate the pro-
inflammatory activity of Th1 cells and, as such, may play 
an immunomodulatory role. The inappropriate selection 
of a type 1 or type 2 phenotype leads to either an ineffec-
tive or a disease-promoting immune response. For exam-
ple, the development of Th2 instead of Th1/Th0 CD4 T 
cells against common airborne allergens leads to allergic 
diseases.8 Similarly, Th1 cells are typically associated with 
organ-specific autoimmune diseases, chronic inflamma-
tory bowel diseases and reactive arthritis.2,6,9 
  The polarization of the immune response is generally 
determined at an early stage and it has been clearly 
established that Th1/Th2 effectors may be derived from 
the same precursor naive T cell.6 Several factors have
Fig. 1 Factors regulating naive T cell differentiation.
bee  implicated in the regulation of naive T cell develop-
ment into Th1 or Th2 effectors (Fig. 1), including: (i) the 
intensity and the nature of the TCR-mediated activation 
signal;10-12 (ii) the strength and the nature of costimulatory 
signals;13-16 (iii) the cytokine and hormonal milieu in 
whi h T cells are primed;17-19 and perhaps also (iv) the 
composition of the extracellular matrix at the site of T cell 
priming. These factors do not act independently of each 
other, the effect of one signal is dependent upon the oth-
ers. The integration of these signals according to the 
genetic background of the naive T cells dictates Th subset 
development.20 How these signals affect cytokine gene 
expression during T cell development and whether genes 
nc ding type 1 or type 2 cytokine are coordinately regu-
lated remain to be determined. Among all the factors 
controlling T cell development, cytokines appear to exert 
the most important role, with IL-4 and IL-12 promoting 
Th2 and Thi responses, respectively.17 The other factors 
may act by altering the endogenous production of 
cytokines at priming. For example (as discussed later), the 
CD40/CD40L costimulation pathway plays an important 
role in the induction of the Th1 response because it is 
required forthe production of IL-12 by DC during antigen 
(Ag) presentation to naive T cells.21,22 
 The cellular origin and the mechanisms leading to the 
early production of IL-12, before or at the time of T cell 
priming, have been elucidated.23,24 Thus, several patho-
gens elicit a protective type 1 response by directly activat-
ing cells of the innate immune system (macrophages,
natural killer (NK) cells, γ/δ T cells) for the early produc-
tion of high levels of IL-12, IFN-γ and perhaps also IFN-
α or TGF-β.25 Interleukin-12 plays an obligatory role in
the induction phase of the Th1 response to these 
pathogens; however, it is not required to maintain it. 
Indeed, delayed treatment of animals infected with 
Listeria monocytogenes or Toxoplasma gondii with anti-
IL-12 antibody (Ab) does not impair their resistance to 
infection nor the cytokine profile of pathogen-specific T 
cells.26,27 Whereas the established Th1 response to at 
least some intracellular pathogens becomes IL-12-inde-
pendent, the Th1 response associated with autoimmune 
or chronic inflammatory disease remains IL-12-depen-
dent and delayed treatment with anti-IL-12 attenuates 
disease progression.9,28,30 Although it has been clearly 
established that IL-4 is the strongest driving force for the 
induction of Th2 responses, the cells responsible for the 
early production of this cytokine at the site of T cell prim-
ing have not yet been clearly identified. Depending on 
the experimental system used to induce a Th2 response,
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different types of cells may be involved in the early pro-
duction of IL-4; that is, γ/δ T cells, natural T cells (some of
which express NK cell markers, such as NK1.1Ag) and 
basophils.31-34 However, as of today, none of these types 
of cells was shown to be required from the development 
of a Th2 response to a simple protein Ag.
HUMAN TH SUBSET DEVELOPMENT 
All of the preceding concepts regarding Th subset devel-
opment are derived from experiments in the mouse 
model, and the maturation of naive human CD4 T cells 
has been much less investigated. Previous studies by 
Romagnani and colleagues2 have analyzed human mem-
ory T cells. These authors were the first to report that the 
lymphokine-producing phenotype of Ag-specific memory 
T cells can be switched in vitro from Th1 to Th2, or vice 
versa, when these cells are restimulated with Ag in the 
presence of the appropriate cytokine or anti-cytokine Ab. 
The ability of IL-12 to convert allergen-specific Th2 cells 
into Th1 cells has been ascribed to a selective expansion 
of the low numbers of Th1/Th0 cells present in the initial 
T cell population rather than to the conversion of nominal 
allergen-specific Th2 to Thl cell.35,36 Indeed, IL-12 does 
not affect the lymphokine-producing capacity of human 
Th2-like cell clones, although it transiently and slightly
increases their production of IFN-γ.4,37 Moreover, T cell
clones derived from freshly isolated peripheral blood 
mononuclear cells (PBMC) which are immediately cloned 
by limiting dilution in the presence of IL-12, display a
normal IL-4 producing capacity but an increased IFN-γ
and IL-10 producing capacity. We have analyzed the in 
vitro maturation of naive human CD4 T cells isolated 
from either umbilical cord blood or from the blood of 
healthy young adults. Naive cells were isolated on the 
basis of their surface phenotype (i. e. CD4+ CD45R0-
CD45RA+ and CD31+). The decision to select for CD31+ 
cells was based on our observation that the CD31 adhe-
sion molecule is also a marker of naive cells, in that it 
progressively disappears after naive T cell activation and 
expansion.38 Owing to the very low frequency of Ag-
specific naive T cells and the inability to prepare human 
TCR-transgenic T cells, naive T cells were primed with 
anti-CD3 monoclonal antibody (mAb), a polyclonal T 
cell activator. In more recent experiments, however, naive 
T cells were primed with highly purified DC as a model of 
Ag-specific T cell development that should allow analysis 
of the interactions between naive T cells and DC.
Naive T cells are capable of producing IL-4
In our initial series of experiments,39 naive T cells were 
activated for 3 days with anti-CD3 mAb immobilized on L
fibroblasts transfected with CD32(FcγRll) and B7.1; at
day 3, T cells were recovered, washed and expanded in 
IL-2 for 3-4 days, in the absence of L cells. Cells primed 
in these conditions display the Th0 phenotype, in that they 
produce readily detectable levels of IL-2, IL-4, IL-5, IL-10,
IFN-γ, lymphotoxin (LT) and TNF-α. When submitted to
multiple cycles of stimulation/IL-2 expansion, in the 
absence of exogenous cytokines (other than IL-2, used to 
expand the cells), the T cells develop into functional Th2-
like cells.39 Assuming that IL-4 is required for the acquisi-
tion of a Th2 phenotype, these observations imply that 
naive T cells, of neonatal or adult origin, are capable of 
producing IL-4 at some time after repetitive stimulation. 
Three series of observations indicate that this is indeed 
the case. 
 (1) Addition of anti-IL-4 neutralizing Ab to primary cul-
tur s results in the development of effector cells produc-
ing much less or no IL-4/IL-5 and increased levels of
IFN-γ.39
 (2) IL-4 mRNA is detected after 48h of naive CD4 T 
cell stimulation with a mixture of soluble anti-CD3 and 
anti-CD28mAb.16 
 (3) IL-4 protein can be measured in the supernatant 
fluids of priming cultures performed in the presence of 
blocking anti-IL-4 receptor mAb (to prevent IL-4 con-
sumption by activated naive T cells).16 Further analysis of 
IL-4 production at priming revealed that it is regulated by 
B7 osignals and cytokines. Increasing B7.1-mediated 
costimulation at the time of T cell priming increases IL-4 
production and, moreover, colligation of TCR/CD3 and 
CD28 with soluble mAbs is sufficient to induce IL-4 
mRNA expression in naive T cells and to promote their 
development into IL-4 producing effectors.16 Interleukin-4 
production in priming cultures is completely suppressed
by TGF β and partly inhibited by saturating concentra-
tions of IFN-γ and IFN-α. Most interestingly, it is unaf-
fected by IL-12. To exclude the possibility that the IL-4 
released in priming cultures could be derived from a
minority subset of cells (NK1.1+-like T cells, γ/δ T cells,
basophils or memory T cells) contaminating the prepara-
tions of naive CD4 T cells, these were directly cloned by 
limiting dilution, immediately after purification from cord 
r adult blood.40 Single naive T cells were grown on 
CD32 B7.1 L transfectants in the presence of anti-CD3 
mAb and IL-2 and were examined for cytokine produc-
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tion. These experiments revealed that each clone pro-
duced IL-4 and IL-5 at generally high levels. Given the 
very high efficiency of the cloning procedure, these results 
indicate that each single naive CD4 T cell is capable of 
differentiating into a high IL-4/IL-5 producer when 
primed and restimulated in the absence of exogenous 
IL-4 as well as IL-4 inhibitors. Addition of saturating con-
centrations of anti-IL-4 + anti-IL-4R mAb to single cell 
cultures leads to the development of clones producing 
much lower but still detectable levels of IL-4 and IL-5, a 
finding consistent with the notion that IL-4 enhances, but 
is not necessary for, the development of IL-4-producing 
cells.
Naive T cells produce a large spectrum of 
cytokines 
It is generally accepted that upon primary activation 
naive CD4 T cells produce mainly (if not exclusively) IL-2, 
which is used as an autocrine growth factor. These cells 
lack effector functions and are much more dependent on 
costimulatory signals than memory T cells for optimal 
activation.41 In addition to producing IL-2, and low but 
functionally sufficient levels of IL-4, we found that naive T
cells also release high levels of type 1 cytokines (IFN-γ, LT
and TNF-α.) together with low, but readily detectable lev-
els of IL-13 and IL-10.42 The production of these cytokines 
is, however, strictly dependent upon appropriate costimu-
lation, explaining why they could not be detected in ear-
lier studies. Naive T cell-derived cytokines may regulate
Fig. 2 Naive T-cell-derived cytokines: Autocrine and paracrine
roles.
Th subset development by an autocrine(IL-2, 4 IFN-γ)
or paracrine (IL-4,IL-13, IL-10, IFN-γ) pathway (Fig. 2).
In addition to IL-4 (see before), IFN-γ was also shown to
regulate T cell differentiation in an autocrine manner.42
lndeed, neutralization of IFN-γ production during pri-
mary T cell activation in an antigen-presenting cell (APC)-
independent system leads to the development of effectors
producing more IL-4 and less IFN-γ.42 Naive T cell-
erived cytokines may act in a paracrine or indirect way 
by controlling the function of APC; that is, their produc-
tion of cytokines (IL-12) and their expression of costimula-
tory molecules. 
Role of IL-12 in the maturation of naive human 
CD4 T cells
In vivo and in vitro studies in the mouse have established 
that IL-12 promotes the development of Th1 responses
(IFN-γ dominated) and often, but not always, inhibits the
induction of Th2 responses (IL-4 dominated).24,43,44 
Various experimental models concur in indicating that IL-
12 primes T cells for increased IFN-y production via a 
direct effect on T cells involving two signals; one medi-
ated by IL-12 itself and the other mediated by IL-12-
induced IFN-γ.17,45 The mechanism whereby IL-12
inhibits the development of IL-4-producing effectors is 
less clear and depends upon several factors, including 
the presence of other cytokines at priming (IL-4) and the 
genetic background of the mice. As already mentioned, 
IL-12 does not inhibit IL-4 production in priming cultures 
of naive human CD4 T cells. However, and most interest-
ingly, it strongly inhibits the production of IL-13 and
markediy enhances that of IFN-γ and IL-2. Nevertheless,
addition of IL-12 to priming cultures polarizes the matu-
ration of naive cells along the Th1 pathway. Indeed, IL-
12-primed cells produce significantly more IL-2, IFN-γ
and TNF-α and significantly less IL-4 and IL-5. The prim-
ing activity of IL-12 for increased IFN-y production is only
partly inhibited by IL-4 and TGF-β whereas its suppressive
effect on IL-4 production is completely overriden by IL-4. 
In some experiments, IL-12 may even enhance IL-4 prim-
ing for increased IL-4 production, a finding that has been 
confirmed in the mouse model, including in STAT 4-
deficient animals.46,47 The ability of IL-12 to inhibit the 
development of IL-4-producing effectors is also critically 
dependent upon the intensity of B7 costimulation. A 
strong B7 cosignal favors the inhibitory effect of IL-12 on 
IL-4 whereas weak B7 costimulation (such as that 
involved when neonatal cells are primed with anti-CD3
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immobilized on CD32L cells, expressing low levels of 
mouse B7.1) has the reverse effect.48 The observation 
that in certain conditions IL-12 may favor the develop-
ment of IL-4 producing cells, is further supported by the 
observations that the addition of IL-12 to long-term cul-
tures of resting unstimulated neonatal CD 4 T cells grown 
in IL-4 promotes their maturation into high IL-4 and IFN-
γ producers. Cells grown in IL-4 alone retoin the pheno-
type and functional features of naive cells.49 The effects of
IL-12 on the IFN-γ and IL-5 producing capacities are
prolonged whereas those on IL-4 are transient. Indeed, 
after 1 month of repetitive stimulation/IL-2 expansion, 
corresponding to a 104-fold cellular expansion, IL-12-
primed cells still produce significantly more IFN-γ and
less IL-5 whereas they produce normal levels of IL-4. 
Thus, IL-12 at priming deviates the phenotype of repeti-
tively stimulated naive T cells from Th2 to Th0. Most inter-
estingly, repetitive stimulation of naive T cells in the 
presence of IL-12 at each cycle results in the development 
of Th1-like cells producing little or no IL-4 and IL-5 and
moderote levels of IFN-γ. These cells are functional Th1
cells in that they are capable of producing very high lev-
els of IFN-γ when stimulated in the presence of IL-12.
These findings further indicate that IL-12 not only primes
naive T cells for increosed IFN-γ production but also for
increased responsiveness to IL-12. Further analysis of this 
phenomenon revealed that IL-12 priming for increased 
responsiveness to IL-12 is very prolonged and still 
detectable after several weeks of stimulation/IL-2 expan-
sion in neutral conditions. Although the mechanisms 
whereby repetitive stimulation of naive cells in the pres-
ence of IL-12 leads to a Th1 phenotype have not been 
explored, we suggest that IL-12 selectively promotes the 
expansion of Thi -like cells rather than inhibiting the IL-4 
producing capacity of IL-4 producing cells. This mecha-
nism, similar to that proposed to explain the ability of IL-
12 to shift the lymphokine-producing phenotype of 
memory allergen-specific T cells from Th2 to Th1, is con-
sistent with two series of observations.37,50,51 First, recently 
generated populations of Th0 or Th1-like cells, similar to 
those obtained after 1 cycle of priming in the presence of 
IL-12, contains a mixture of Th2, Thi and Th0 cells.5o,51, 
Second, T cell clones derived from freshly isolated naive 
CD4 T cells grown in the presence of IL-12 display a nor-
mol IL-4 producing copocity but Qn increased IFN-γ and
IL-10 producing capacity.37 From all the preceding obser-
vations we conclude that: (i) IL-12 at priming exerts pro-
longed and pronounced effects on the capacity of primed
cells to produce IFN-γ and　IL-5 and to respond to IL-12;
(ii) in the absence of accessory cell-derived cytokines
(TGF-β, IFN-α and perhops other cytokines), IL-12 is
necessary not only to induce but also to maintain a Th1 
phenotype; and (iii) IL-12 acts by selectively favorina the
exponsion of IFN-γ producing cells rather than by directly
inhibiting IL-4 gene expression. This selection might be
medioted by IL-12-induced IFN-γ, which is known to
nhibit the proliferation of mouse Th2 clones.52 However, 
the failure to inhibit the effect of IL-12 by neutralizing Ab
to IFN-γ does not support this possibility. An attractive
possibility would be that IL-12 favors Fas L mediated 
killi g of IL-4 producing cells by Th1-like cells.7,53 
In vitro maturation of antigen-specific naive 
human CD4 T cells 
I  more recent experiments, neonatal CD4 T cells were 
primed with allogenic DC as a model to analyze the mat-
uration of Ag-specific naive T cells and their cross-talk 
with professional APC.21 Highly purified DC, isolated by 
negative selection from the blood of healthy individuals, 
stimulate neonatal T cell proliferation and maturation 
into effector cells displaying a Th0 or Th1-like phenotype 
depending upon the intensity of the allogenic stimulation. 
Several cytokines are produced in these priming cultures,
including IFN一 ・y, IL高40nd IL-12一The produc†ion of IFN一 γ
is markedly enhanced by neutralizing mAb to IL-4, con-
firming the notion that naive T cells release functionally
sufficien†levels of IL-4. The production of IFN-γ is moder-
ately but significantly suppressed by anti-IL-12 Ab, sug-
gesting that DC release IL-12 upon interaction with naive 
T cells. Indeed, IL-12 p40 is detectable at variable but 
generally low levels in most of the priming cultures and
the levels of IL-12 p40 and IFN-γ　are significantly corre-
lated. IL-12 production is completely suppressed by the 
addition of exogenous IL-4 to priming cultures and it is 
markedly enhanced by neutralizing anti-IL-4R mAb, indi-
cati g that endogenous IL-4 released by naive T cells 
dow regulates IL-12 production by DC. T cells primed in 
the presence of anti-IL-4R mAb display a Th1 instead of a 
Th0 phenotype and, most interestingly, this shift is pre-
vented by anti-IL-12 Ab, indicating that the effects of anti-
IL-4 are IL-12-dependent. Thus the cytokine profile of 
all antigen-primed cells is regulated by the endogenous 
production of IL-4 (T cell- erived) and IL-12 (DC-derived) 
at priming. As IL-12 p40 is not produced in cultures con-
taining either naive T cells alone or DC alone, the data 
indicate that IL-12 is produced as a result of cellular inter-
actions between these two types of cells. Further to our
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initial observations that CD40L expressed on activated T 
cells induces IL-12 production by cytokine-primed mono-
cytes by engaging CD40 on the surface of these cells,54 
we have examined the role of CD40L/CD40 interaction 
during T cell priming. As expected, addition of anti-
CD40L mAb to priming cultures strongly inhibits IL-12 
production suggesting that CD40L expressed on acti-
vated naive T cells engages CD40 on DC and triggers 
these cells to release IL-12. Consistent with this interpre-
tation are the findings that: (i) DC constitutively express 
CD40;55 (ii) activated naive T cells express high levels of 
CD40L;56 and (iii) recombinant soluble CD40L 
(sCD40L), or CD40L transfectants induces IL-12 produc-
tion by DC.57,58 As indicated, freshly isolated peripheral 
blood DC produce low levels of IL-12 upon interaction 
with naive T cells or upon stimulation with sCD40L. Most 
importantly, we and others have observed that preincu-
bation of DC with certain cytokines may significantly 
increase their ability to produce IL-12 upon stimulation 
with CD40L.57,58 Thus, the cytokine environment to which 
DC are exposed markedly influences their IL-12 produc-
ing capacity and thus their ability to polarize Th subset 
development. Finally and most interestingly, CD40L on 
activated naive T cells also stimulates the expression of 
costimulatory molecules on DC, including B7.2 and 
B7.157,59-62 (Fig. 3). It has been shown that engagement of
CD40L on T cells by CD40 Ag costimulates T prolifera-
tion.63 Two recent studies further indicated that this co-
stimulation pathway increases cytokine production by T 
cells;64,65 according to one study this enhancing effect is 
selective for IL-4 and IL-10,64 whereas in the second study 
both type 1 and type 2 cytokines are increased upon 
engagement of CD40L.65 From these experiments we 
suggest that in neutral conditions, Ag presentation by DC 
results in the coordinate production of naive T cell-
derived IL-4 and DC-derived IL-12, which in concert 
shape the cytokine profile of Th cells. The levels of 
endogenous IL-4 and IL-12 are undoubtedly controlled
Fig. 3 CD40/CD40-L interactions during T cell priming.
by the genetic background and the form of antigenic 
stimulation, as well as the state of activation of the APC. 
Th  data also reinforce the notion that the role of 
end genous IL-4 is predominant over that of IL-12 in that 
it suppresses both the production and the effects of IL-12. 
CONCLUSION 
As m ntioned, the dichotomy of Th subsets is less 
absolute in the human than in the mouse system and
humon Th2-cell clones retoin the ability to produce IFN-γ
and IL-2. Human Th2 cell clones still respond to IL-12 
and are capable of inducing IL-12 production upon cog-
nat  or non-cognate interactions within DC but not with 
monocytes.5 Most interestingly, human Th2 clones may 
express four distinct cytokine profiles depending upon the 
type of ARC with which they interact and the type of acti-
vation signal they receive (TCR-mediated versus IL-2). 
These four cytokine profiles include: (i) IL-4+IL-5, in 
response to anti-CD3 mAb and monocytes; (ii) IL-4+IL-
5+IFN γ, in response to anti-CD3 and DC; (iii) IL-5
alone in response to IL-2 and monocytes; and (iv) IL-
5+IFN-γ, in response to IL-12 and DC. Whereos the pro-
duction of IL-4 requires TCR-mediated stimulation, the 
production of the proinflammatory cytokines IL-5 and
lFN一 ・ゾdoes not, but is dependentupon contact-mediated
costimulatory signals. The production of IFN-γ, but not
IL-5, is secondary to the release of IL-12 by DC upon 
cognate or non-cognate interactions with Th2 cells in 
which CD40/CD40L molecules play an important role. 
These observations explain the heterogeneity of cytokines 
produced at the sites of typical Th2-mediated diseases, 
like atopic dermatitis. 
 With these restrictions in mind, we propose the follow-
ing hypothetical model for the development of a polar-
ized Th1/Th2 response to soluble protein Ag that are 
devoid of adjuvant activity; that is, that do not recruit or 
activate cells of the innate immune system (Fig. 4). In 
each case we assume that: (i) naive T cells are primed by
Ag presented by DC; and (ii) initial priming is essential 
but not sufficient for a full polarization of the response, 
which requires multiple rounds of restimulation in appro-
priate conditions. Priming conditions favoring Th1 
response include: (i) appropriate genetic background; (ii) 
strong TCR-mediated stimulation; and (iii) cytokine-
primed or pre-activated DC capable of producing high 
levels of IL-12. Cells primed in these conditions display a 
Th0-like phenotype, characterized by the production of
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Fig. 4 (a) Thl and (b) Th2 response to protein antigen.
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relatively high levels of IFN-y and low levels of IL-4/IL-5. 
These cells are highly responsive to IL-12 and will 
develop into Thl effectors after multiple restimulations by 
Ag presented on IL-12-producing APC. In this model, IL-
12 is necessary not only for the induction and the devel-
opment, but also for the maintenance and the 
expression, of the Th1 response. 
 Priming conditions favoring Th2 response include: (i) 
appropriate genetic background; (ii) weak TCR-mediated 
stimulation; and (iii) 'resting' DC capable of expressing 
costimulatory signals (B7.2, 7.1) but producing low levels 
of IL-12. Cells primed in these conditions produce IL-
4/IL-5 and moderote to low levels of IFN-γ. Their Bevel-
opment into Th2-like effectors requires multiple rounds of 
restimulation by Ag presented on ARC such as B cells, 
which do not produce IL-12.66,67 According to this model, 
the polarization is never absolute and is therefore poten-
tially reversible. Thus, the Th1 response to auto-antigens 
could be interrupted by blocking the IL-12 pathway and 
conversely the Th2 response to allergens might be redi-
rected by interference with ARC (IL-12 production) and/or 
IL-4 production.
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